Prescribe to Prevent HIV: A Hybrid Trial Helping Addiction Clinics Prevent HIV & Infections Through Safer Drug Use Support

NANot yet recruitingINTERVENTIONAL
Enrollment

536

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

June 30, 2028

Conditions
People Who Use Opioids/People With Opioid Use Disorder (OUD)
Interventions
BEHAVIORAL

Implementation strategy bundle

The anticipated strategy bundle will include integrated patient-, provider-, and system-level interventions to support sustainable implementation. At the patient level, this may involve education, peer support, and navigation services; at the provider level, training, decision-support tools, and workflow enhancements; and at the system level, policy changes, electronic health record integration, and organizational alignment to promote and maintain prescribing of PrEP and injection equipment.

Trial Locations (4)

15132

Latterman Family Health Center, Pittsburgh

15213

Center for Psychiatric And Chemical Dependency Services, Pittsburgh

Internal Medicine Recovery Engagement Program, Pittsburgh

UPMC Magee-Womens Hospital, Pittsburgh

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Pittsburgh

OTHER

NCT07073924 - Prescribe to Prevent HIV: A Hybrid Trial Helping Addiction Clinics Prevent HIV & Infections Through Safer Drug Use Support | Biotech Hunter | Biotech Hunter